The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators.

Cathepsin F is a lysosomal cysteine protease of the papain family, and likely plays a regulatory role in processing the invariant chain that is associated with the major histocompatibility complex (MHC) class II. Evidence suggests that inhibiting cathepsin F activity will block MHC class II processing in macrophages. Consequently, inhibitors of this enzyme may be useful in treating certain diseases that involve an inappropriate or excessive immune response. We have determined the 1.7A structure of the mature domain of human cathepsin F associated with an irreversible vinyl sulfone inhibitor. This structure provides a basis for understanding cathepsin F's substrate specificity, and suggests ways of identifying potent and selective inhibitors of this enzyme.

[1]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[2]  D Lamba,et al.  Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases , 2001, The EMBO journal.

[3]  J. Shafer,et al.  Potentiometric determination of ionizations at the active site of papain. , 1976, Biochemistry.

[4]  R. Bohacek,et al.  Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design. , 2001, Journal of medicinal chemistry.

[5]  L. Sluyterman,et al.  Proton equilibria in the binding of Zn2+ and of methylmercuric iodide to papain. , 1976, European journal of biochemistry.

[6]  A. Rudensky,et al.  Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. , 1998, Science.

[7]  H. Ploegh,et al.  Role for Cathepsin F in Invariant Chain Processing and Major Histocompatibility Complex Class II Peptide Loading by Macrophages , 2000, The Journal of experimental medicine.

[8]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[9]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[10]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[11]  J T Palmer,et al.  Crystal structure of human cathepsin S , 1998, Protein science : a publication of the Protein Society.

[12]  R. DesJarlais,et al.  Structure-based design of non-peptide, carbohydrazide-based cathepsin K inhibitors. , 1999, Bioorganic & medicinal chemistry.

[13]  R. Ménard,et al.  Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. , 1996, The EMBO journal.

[14]  Mary E. McGrath,et al.  Crystal structure of human cathepsin K complexed with a potent inhibitor , 1997, Nature Structural Biology.

[15]  E. Mehler,et al.  Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. , 1999, Biochemistry.

[16]  R. Huber,et al.  Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors. , 1995, Biochemistry.

[17]  D. Turk,et al.  Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease. , 2000, Structure.

[18]  D. Turk,et al.  Crystal structure of porcine cathepsin H determined at 2.1 A resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function. , 1998, Structure.

[19]  J. Palmer,et al.  Vinyl sulfones as mechanism-based cysteine protease inhibitors. , 1995, Journal of medicinal chemistry.

[20]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[21]  Hidde L. Ploegh,et al.  Cathepsin S Controls the Trafficking and Maturation of Mhc Class II Molecules in Dendritic Cells , 1999, The Journal of cell biology.

[22]  P. Roche,et al.  Trafficking of MHC class II molecules in the late secretory pathway. , 2002, Current opinion in immunology.

[23]  J. Nowick,et al.  An improved method for the synthesis of enantiomerically pure amino acid ester isocyanates , 1992 .

[24]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[25]  E A Merritt,et al.  Raster3D Version 2.0. A program for photorealistic molecular graphics. , 1994, Acta crystallographica. Section D, Biological crystallography.

[26]  L. Polgár.  Mercaptide—imidazolium ion‐pair: The reactive nucleophile in papain catalysis , 1974, FEBS letters.

[27]  R J Fletterick,et al.  A target within the target: probing cruzain's P1' site to define structural determinants for the Chagas' disease protease. , 2000, Structure.

[28]  P. Selzer,et al.  Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors. , 1998, Bioorganic & medicinal chemistry.